Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus

Completed · Phase 1 · Has a placebo group

Conditions studied: Type 1 Diabetes Mellitus

In brief

A study to examine the effect of pioglitazone on the course of new onset type 1 diabetes mellitus.

Key facts

Study ID

NCT00545857

Run by

Stony Brook University

People needed

15

Starts

2002-06-01

Expected to finish

2012-05-01

Last updated by the study team

2012-05-31

Who can join

Age: 6 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with type 1 diabetes mellitus diagnosed within 4 months
• Age > 6 years of age
• Ability to swallow capsule
• Signed informed consent / assent

You may not qualify if…

• Other illnesses

Where it is running

• Thomas A. Wilson, MD — Stony Brook, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.